CV-19 therapeutic drug trials and Vaccine

The Off-Topic forum for anything non-LDS related, such as sports or politics. Rated PG through PG-13.
_Jersey Girl
_Emeritus
Posts: 34407
Joined: Wed Oct 25, 2006 1:16 am

Re: CV-19 therapeutic drug trials and Vaccine

Post by _Jersey Girl »

I don't get colds at all. Probably because I practiced all the social distancing and hygiene things for decades at work and home. I also tend to stay out of crowded stores during the cold and flu season. Like, my Christmas shopping is already done and I'll continue to use grocery pick up--best invention ever! Pre-masks I used my coat sleeve (the elbow area or neck area depending on the style) as a mask (done that for years) and the sleeve cuffs to cover my hands to open doors. I learned to open doors with my coat sleeve over my hand back in the classroom. I do it automatically. You just flop your coat sleeve down over your hand and open the door. Pro-tip. ;-)

Watch. Now I'll start sneezing in an hour! :lol:
Failure is not falling down but refusing to get up.
Chinese Proverb
_Gunnar
_Emeritus
Posts: 6315
Joined: Sat Aug 11, 2012 6:17 am

Re: CV-19 therapeutic drug trials and Vaccine

Post by _Gunnar »

Good tips, Jersey Girl. I'm going to take them to heart. I admit I haven't in the past followed those practices as rigidly as you have. Still, I don't catch colds as often as I used to, and they don't seem to be as bad or long lasting as they used to be. Maybe that is partly because at my age I have been exposed to more different strains of cold virus than someone much younger, and have consequently built up a larger variety of antibodies to different strains of cold viruses.
No precept or claim is more likely to be false than one that can only be supported by invoking the claim of Divine authority for it--no matter who or what claims such authority.

“If you make people think they're thinking, they'll love you; but if you really make them think, they'll hate you.”
― Harlan Ellison
_Jersey Girl
_Emeritus
Posts: 34407
Joined: Wed Oct 25, 2006 1:16 am

Re: CV-19 therapeutic drug trials and Vaccine

Post by _Jersey Girl »

I'll make that into a list.

Opening doors:

Flop your sleeve over your hand. Open the door with your sleeved hand. Do the same thing on grocery cart handles and baskets. It will be come reflex. Especially if you do it for 30 years. :biggrin:

Masking without a mask:


Use the collar or upper part of your jacket, use the jacket to cover your nose/mouth.

If someone sneezes or coughs around you, put your sleeved arm in front of your face (elbow), turn around and walk the other way. Do NOT walk into their contagious "mist". :eek:

Masking without a mask on airplanes:

Same techniques as above. When you get on the plane, keep your jacket on, pull the jacket up over your nose and mouth like a turtle going into a shell...you will look like a thug but I think it works. Sleeping on long haul flights: Throw a blanket over your head. Done both of these many times!

Summary: Don't touch anything with your bare hands. Cover your nose and mouth--learn not to care what people think of you. It's your life, not theirs.

Of course we all have masks now, but in a pinch, you can do any of the above especially if you are touching doors, basket and cart handles. I keep some vinyl gloves in the car, sometimes I forget to bring them in so I automatically go back to the sleeve technique. At other times I simply drench the cart and basket handles in hand sanitizer.

When I get back to the car, I hand sanitize my bank card, my keys, door handles (anything else I touched getting in the car) and my hands. Don't forget to scrub it all up, that's (friction) what breaks up and destroys the virus cells.

So far, so good!
Failure is not falling down but refusing to get up.
Chinese Proverb
_Chap
_Emeritus
Posts: 14190
Joined: Mon Jun 11, 2007 10:23 am

Re: CV-19 therapeutic drug trials and Vaccine

Post by _Chap »

With all due caution, as indicated in the article, I think this counts as encouraging, or at least interesting news:

Oxford Covid vaccine works in all ages, trials suggest
Vaccine being trialled by Oxford University and AstraZeneca offers hope for all age groups

One of the world’s leading Covid-19 experimental vaccines produces an immune response in older adults as well as the young, its developers say, raising hopes of protection for those most vulnerable to the coronavirus that has caused social and economic chaos around the world.

Neither Oxford University nor its commercial partner AstraZeneca would release the data from the early trials showing the positive effects, which are being submitted to a peer-reviewed journal. But AstraZeneca confirmed the basic findings about the vaccine it calls AZD1222, which were shared at a closed academic meeting.

The phase 2 trials have shown that people over the age of 56 – and some over 70 – produced the same sort of antibody response as younger volunteers. Whether older people would be protected has always been a key question for the vaccines being developed. The body’s natural immune system and therefore its ability to fight any virus weakens with age, which is why the Covid death rate rises in older people.

The data also shows that fewer side-effects – referred to by the scientists as “reactogenicity” – were reported in the older volunteers, which is encouraging, although it could mean fewer of them reported issues such as a sore arm.

“It is encouraging to see immunogenicity responses were similar between older and younger adults and that reactogenicity was lower in older adults, where the Covid-19 disease severity is higher. The results further build the body of evidence for the safety and immunogenicity of AZD1222,” said an AstraZeneca spokesman.

A vaccine that works is seen as a game-changer in the battle against coronavirus, which has killed more than 1.15 million people, shuttered swathes of the global economy and turned normal life upside down for billions of people. However, few think the first vaccines will be fully protective. They may instead reduce the severity of illness, so that people avoid hospital and deaths are reduced. They may also not last, so that boosters will be needed.

AstraZeneca said it hoped the vaccine may be ready for limited use within the coming months. “We anticipate efficacy read-outs from phase 2/3 trials between now and the end of the year, and if approved within countries, doses of the potential vaccine could be available for use before the end of the year,” said the spokesperson.

However, most experts outside the company, and the UK health secretary, Matt Hancock, expect it not to be available until 2021. Asked if some people could receive a vaccine this year, Hancock told the BBC: “I don’t rule that out but that is not my central expectation.”

Hancock said a vaccine was not yet ready but he was preparing logistics for a possible rollout, mostly in the first half of 2021. AstraZeneca has committed to mass manufacturing and has a capacity of 3bn doses – which equates to enough for 1.5 billion people globally getting the two-dose vaccine. It has also signed deals with manufacturers in other countries, such as India.

The final trials (phase 3), looking to see a significant difference in the numbers of deaths between those vaccinated and those who are not, are taking place in six countries. Trials in the US, which were paused after a volunteer in the UK became ill, have resumed. The other countries participating are South Africa, Brazil, Japan and India.

The vaccine is expected to be one of the first from big pharma to secure regulatory approval, along with one from Pfizer and BioNTech.

Work began on the Oxford vaccine in January. Called AZD1222 or ChAdOx1 nCoV-19, the viral-vector vaccine is made from a weakened version of a common cold virus that causes infections in chimpanzees.

Stephen Evans, a professor of pharmacoepidemiology at the London School of Hygiene & Tropical Medicine, cautioned that no conclusions about the efficacy of the vaccine should be drawn until the data had been published.

“In order to comment properly on this we need to see the data,” he said. “It is encouraging that the investigators suggest that the immune responses measured in the blood seem to show efficacy both above, as well as below, age 70. The later phase trials are needed to see if the immune responses translate into clinical efficacy in preventing infection. These will involve much larger numbers and it is wise to not be too optimistic until those trials have completed.”

Raised antibody levels in the blood indicated but did not guarantee protection from the virus multiplying in the body, he said.
Zadok:
I did not have a faith crisis. I discovered that the Church was having a truth crisis.
Maksutov:
That's the problem with this supernatural stuff, it doesn't really solve anything. It's a placeholder for ignorance.
_Gunnar
_Emeritus
Posts: 6315
Joined: Sat Aug 11, 2012 6:17 am

Re: CV-19 therapeutic drug trials and Vaccine

Post by _Gunnar »

Jersey Girl wrote:
Mon Oct 26, 2020 6:49 pm
I don't get colds at all. Probably because I practiced all the social distancing and hygiene things for decades at work and home. I also tend to stay out of crowded stores during the cold and flu season. Like, my Christmas shopping is already done and I'll continue to use grocery pick up--best invention ever! Pre-masks I used my coat sleeve (the elbow area or neck area depending on the style) as a mask (done that for years) and the sleeve cuffs to cover my hands to open doors. I learned to open doors with my coat sleeve over my hand back in the classroom. I do it automatically. You just flop your coat sleeve down over your hand and open the door. Pro-tip. ;-)

Watch. Now I'll start sneezing in an hour! :lol:
If so, gesundheit! :wink:
No precept or claim is more likely to be false than one that can only be supported by invoking the claim of Divine authority for it--no matter who or what claims such authority.

“If you make people think they're thinking, they'll love you; but if you really make them think, they'll hate you.”
― Harlan Ellison
Post Reply